Last reviewed · How we verify

NCT06782152

AVEIR™ Leadless Pacemaker Registry in Europe and MIddle East Region (PREMIER LEADLESS)

Not yet recruiting Last updated 17 January 2025
What this trial tests

trial in Cardiac Pacing in Adherence With ESC Cardiac Pacing Guidelines in 1,698 participants. Not yet recruiting.

Timeline
6 January 2025
Primary endpoint
31 December 2028
31 December 2028

Quick facts

Lead sponsorKing Fahad Armed Forces Hospital
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment1,698
Start date6 January 2025
Primary completion31 December 2028
Estimated completion31 December 2028

Conditions studied

Sponsor

King Fahad Armed Forces Hospital

Who can join

18 and older, any sex, with Cardiac Pacing in Adherence With ESC Cardiac Pacing Guidelines. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The AVEIR™ Leadless Pacemaker Registry (herein referred to as "PREMIER LEADLESS Registry") is a prospective, multicenter, International, open label observational study designed to evaluate safety and electrical performances of AVEIR™ leadless pacemakers used in real-world clinical practice and to evaluate clinical outcomes and characteristics of patients treated with these leadless devices.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other King Fahad Armed Forces Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06782152.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing